4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Role of TMEM100 in mechanically insensitive nociceptor un-silencing

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mechanically silent nociceptors are sensory afferents that are insensitive to noxious mechanical stimuli under normal conditions but become sensitized to such stimuli during inflammation. Using RNA-sequencing and quantitative RT-PCR we demonstrate that inflammation upregulates the expression of the transmembrane protein TMEM100 in silent nociceptors and electrophysiology revealed that over-expression of TMEM100 is required and sufficient to un-silence silent nociceptors in mice. Moreover, we show that mice lacking TMEM100 do not develop secondary mechanical hypersensitivity—i.e., pain hypersensitivity that spreads beyond the site of inflammation—during knee joint inflammation and that AAV-mediated overexpression of TMEM100 in articular afferents in the absence of inflammation is sufficient to induce mechanical hypersensitivity in remote skin regions without causing knee joint pain. Thus, our work identifies TMEM100 as a key regulator of silent nociceptor un-silencing and reveals a physiological role for this hitherto enigmatic afferent subclass in triggering spatially remote secondary mechanical hypersensitivity during inflammation.

          Abstract

          Silent nociceptors remained enigmatic ever since they were first described decades ago. Here, Nees. et al. show that inflammation-induced upregulation of TMEM100 unsilences silent nociceptors, which triggers secondary mechanical pain hypersensitivity.

          Related collections

          Most cited references59

          • Record: found
          • Abstract: found
          • Article: not found

          Full-length RNA-seq from single cells using Smart-seq2.

          Emerging methods for the accurate quantification of gene expression in individual cells hold promise for revealing the extent, function and origins of cell-to-cell variability. Different high-throughput methods for single-cell RNA-seq have been introduced that vary in coverage, sensitivity and multiplexing ability. We recently introduced Smart-seq for transcriptome analysis from single cells, and we subsequently optimized the method for improved sensitivity, accuracy and full-length coverage across transcripts. Here we present a detailed protocol for Smart-seq2 that allows the generation of full-length cDNA and sequencing libraries by using standard reagents. The entire protocol takes ∼2 d from cell picking to having a final library ready for sequencing; sequencing will require an additional 1-3 d depending on the strategy and sequencer. The current limitations are the lack of strand specificity and the inability to detect nonpolyadenylated (polyA(-)) RNA.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Molecular Architecture of the Mouse Nervous System

            Summary The mammalian nervous system executes complex behaviors controlled by specialized, precisely positioned, and interacting cell types. Here, we used RNA sequencing of half a million single cells to create a detailed census of cell types in the mouse nervous system. We mapped cell types spatially and derived a hierarchical, data-driven taxonomy. Neurons were the most diverse and were grouped by developmental anatomical units and by the expression of neurotransmitters and neuropeptides. Neuronal diversity was driven by genes encoding cell identity, synaptic connectivity, neurotransmission, and membrane conductance. We discovered seven distinct, regionally restricted astrocyte types that obeyed developmental boundaries and correlated with the spatial distribution of key glutamate and glycine neurotransmitters. In contrast, oligodendrocytes showed a loss of regional identity followed by a secondary diversification. The resource presented here lays a solid foundation for understanding the molecular architecture of the mammalian nervous system and enables genetic manipulation of specific cell types.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Central sensitization: implications for the diagnosis and treatment of pain.

              Nociceptor inputs can trigger a prolonged but reversible increase in the excitability and synaptic efficacy of neurons in central nociceptive pathways, the phenomenon of central sensitization. Central sensitization manifests as pain hypersensitivity, particularly dynamic tactile allodynia, secondary punctate or pressure hyperalgesia, aftersensations, and enhanced temporal summation. It can be readily and rapidly elicited in human volunteers by diverse experimental noxious conditioning stimuli to skin, muscles or viscera, and in addition to producing pain hypersensitivity, results in secondary changes in brain activity that can be detected by electrophysiological or imaging techniques. Studies in clinical cohorts reveal changes in pain sensitivity that have been interpreted as revealing an important contribution of central sensitization to the pain phenotype in patients with fibromyalgia, osteoarthritis, musculoskeletal disorders with generalized pain hypersensitivity, headache, temporomandibular joint disorders, dental pain, neuropathic pain, visceral pain hypersensitivity disorders and post-surgical pain. The comorbidity of those pain hypersensitivity syndromes that present in the absence of inflammation or a neural lesion, their similar pattern of clinical presentation and response to centrally acting analgesics, may reflect a commonality of central sensitization to their pathophysiology. An important question that still needs to be determined is whether there are individuals with a higher inherited propensity for developing central sensitization than others, and if so, whether this conveys an increased risk in both developing conditions with pain hypersensitivity, and their chronification. Diagnostic criteria to establish the presence of central sensitization in patients will greatly assist the phenotyping of patients for choosing treatments that produce analgesia by normalizing hyperexcitable central neural activity. We have certainly come a long way since the first discovery of activity-dependent synaptic plasticity in the spinal cord and the revelation that it occurs and produces pain hypersensitivity in patients. Nevertheless, discovering the genetic and environmental contributors to and objective biomarkers of central sensitization will be highly beneficial, as will additional treatment options to prevent or reduce this prevalent and promiscuous form of pain plasticity. Copyright © 2010 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                s.lechner@uke.de
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                5 April 2023
                5 April 2023
                2023
                : 14
                : 1899
                Affiliations
                [1 ]GRID grid.7700.0, ISNI 0000 0001 2190 4373, Institute of Pharmacology, , Heidelberg University, ; Heidelberg, Germany
                [2 ]GRID grid.5253.1, ISNI 0000 0001 0328 4908, Department for Orthopeadics, , Heidelberg University Hospital, ; Heidelberg, Germany
                [3 ]GRID grid.440747.4, ISNI 0000 0001 0473 0092, Institute of Pathophysiology, , Yan’an University, ; Yan’an, China
                [4 ]GRID grid.13648.38, ISNI 0000 0001 2180 3484, Department of Anesthesiology, , University Medical Center Hamburg-Eppendorf, ; Hamburg, Germany
                [5 ]GRID grid.5970.b, ISNI 0000 0004 1762 9868, SISSA: Scuola Internazionale Superiore di Studi Avanzati, ; Trieste, Italy
                [6 ]GRID grid.419491.0, ISNI 0000 0001 1014 0849, Department of Neuroscience, , Max Delbrück Center for Molecular Medicine, ; Berlin, Germany
                [7 ]GRID grid.256155.0, ISNI 0000 0004 0647 2973, Department of Biochemistry, Lee Gil Ya Cancer and Diabetes Institute, , Gachon University College of Medicine, ; Incheon, Republic of Korea
                [8 ]GRID grid.26811.3c, ISNI 0000 0001 0586 4893, Instituto de Neurosciencias de Alicante, , Universidad Miguel Hernández – CSIC, ; Alicante, Spain
                Author information
                http://orcid.org/0000-0002-7131-6016
                http://orcid.org/0000-0003-4332-7049
                http://orcid.org/0000-0001-7917-9012
                http://orcid.org/0000-0002-3841-1994
                http://orcid.org/0000-0002-9343-7580
                http://orcid.org/0000-0002-2890-6352
                http://orcid.org/0000-0001-9402-9127
                Article
                37602
                10.1038/s41467-023-37602-w
                10076432
                37019973
                0ac2d9a7-afbb-4e68-8e51-35486da03fa7
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 4 October 2022
                : 23 March 2023
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100001659, Deutsche Forschungsgemeinschaft (German Research Foundation);
                Award ID: SFB1158.A01
                Award Recipient :
                Categories
                Article
                Custom metadata
                © The Author(s) 2023

                Uncategorized
                chronic pain,somatic system,neuronal physiology
                Uncategorized
                chronic pain, somatic system, neuronal physiology

                Comments

                Comment on this article